Literature DB >> 32578352

A Mendelian randomization study of the causal association between anxiety phenotypes and schizophrenia.

Hannah J Jones1,2,3, David Martin2, Sarah J Lewis1,4, George Davey Smith1, Michael C O'Donovan5, Michael J Owen5, James T R Walters5, Stanley Zammit2,5.   

Abstract

Schizophrenia shows a genetic correlation with both anxiety disorder and neuroticism, a trait strongly associated with anxiety. However, genetic correlations do not discern causality from genetic confounding. We therefore aimed to investigate whether anxiety-related phenotypes lie on the causal pathway to schizophrenia using Mendelian randomization (MR). Four MR methods, each with different assumptions regarding instrument validity, were used to investigate casual associations of anxiety and neuroticism related phenotypes on schizophrenia, and vice versa: inverse variance weighted (IVW), weighted median, weighted mode, and, when appropriate, MR Egger regression. MR provided evidence of a causal effect of neuroticism on schizophrenia (IVW odds ratio [OR]: 1.33, 95% confidence interval [CI]: 1.12-1.59), but only weak evidence of a causal effect of anxiety on schizophrenia (IVW OR: 1.10, 95% CI: 1.01-1.19). There was also evidence of a causal association from schizophrenia liability to anxiety disorder (IVW OR: 1.28, 95% CI: 1.18-1.39) and worry (IVW beta: 0.05, 95% CI: 0.03-0.07), but effect estimates from schizophrenia to neuroticism were inconsistent in the main analysis. The evidence of neuroticism increasing schizophrenia risk provided by our results supports future efforts to evaluate neuroticism- or anxiety-based therapies to prevent onset of psychotic disorders.
© 2020 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics published by Wiley Periodicals LLC.

Entities:  

Keywords:  Mendelian randomization; anxiety; neuroticism; schizophrenia

Mesh:

Year:  2020        PMID: 32578352     DOI: 10.1002/ajmg.b.32808

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  2 in total

1.  Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes.

Authors:  Zoe E Reed; Robyn E Wootton; Marcus R Munafò
Journal:  Addiction       Date:  2021-09-29       Impact factor: 7.256

Review 2.  Mendelian randomisation for psychiatry: how does it work, and what can it tell us?

Authors:  Robyn E Wootton; Hannah J Jones; Hannah M Sallis
Journal:  Mol Psychiatry       Date:  2021-06-04       Impact factor: 15.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.